Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them


Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them

02-Nov-2020 / 18:30 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


 

Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them

 

 

1. Contact information for the person discharging managerial responsibilities or the closely related person

 

Company name: Sartorius AG

Legal form: AG (Aktiengesellschaft)

 

2. Reason for notification

 

The declarant is a closely related person referred to in Article 3.26) of EU Regulation 596/2014 of April 16, 2014 on market abuse.

 

Please specify the positions held within the issuer.

 

Positions:  i. Joachim Kreuzburg is chairman and CEO of Sartorius Stedim Biotech SA and chairman of the management board of Sartorius AG;

ii. Dr. René Fáber is a member of the board of Sartorius Stedim Biotech SA and a member of the management board of Sartorius AG;

iii. Dr. Lothar Kappich is a member of the board of Sartorius Stedim Biotech SA and chairman of the supervisory board of Sartorius AG.

 

This is an initial notification.

 

3. Contact information of the issuer

 

Company name: Sartorius Stedim Biotech S.A.

LEI: 52990006IVXY7GCSSR39

 

4. Information about the transaction

 

Date of the transaction: 02/11/2020

Place of the transaction: outside a trading venue

Nature of the transaction: sale

Description of the financial instrument: shares

Identification code: FR0013154002

 

Detailed information by transaction:

Unit price: EUR 327.00

Volume: 405,887 shares

 

Aggregated information:

Weighted average price: EUR 327.00

Volume: 405,887 shares

 

The transaction is NOT related to the exercise of a stock option program or to a bonus or performance share grant.

 

5. Comments

 

Ø


Regulatory filing PDF file

File: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them


Language: English
Company: Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone: +33 44 284 5600
E-mail: [email protected]
Internet: www.sartorius-stedim.com
ISIN: FR0013154002
Euronext Ticker: DIM
AMF Category: Inside information / Other releases
EQS News ID: 1144863
 
End of Announcement EQS News Service

1144863  02-Nov-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1144863&application_name=news&site_id=sharewise

Sartorius Stedim Biotech S.A. Aktie

156,65 €
2,31 %
Ein deutlicher Gewinn bei Sartorius Stedim Biotech S.A. heute, um 2,31 %.

Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare